Purchase Order 75N94021P00134
Award Date 1/30/21
Potential Completion Date 3/11/22
Potential Value $224K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. on June 28, 2018, for $14,026.27, with ultimate completion on August 23, 2018. The order covers service agreement support for CBOT and HiSeq sequencers at the agency's Bethesda, Maryland facility. Pricing is firm fixed.</p>
- The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $201,059.24 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomics analysis instruments and reagents, for an annual NextSeq 550 sequencing instrument service plan. The contract has a base year from April 30, 2022 to April 29, 2023 with four one-year option periods. Illumina is the sole authorized service provider...
- The Department of Health and Human Services' National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm fixed-price delivery order contract to Illumina, Inc., a for-profit manufacturer of sequencing and genomics analysis equipment. The $193,926.00 contract, which has a completion date of September 2, 2025, is for the provision of consumables to support NIDDK's research and diagnostic activities. Illumina has a history of federal contract...
- <p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. for $68,481.22 on August 13, 2018, with ultimate completion on June 22, 2019. The order covers a service agreement for HiSeq2500 and CBOT sequencing instrumentation. Work is performed at Bethesda, Maryland. Pricing is firm fixed price with no small business set-aside applied.</p>
- <p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. for $66,000 on December 30, 2019, for service on a HiSeq 3000 instrument supporting the NIDDK Genomics Core. Work is performed in San Diego, California. The order carries firm fixed price terms and an ultimate completion date of December 29, 2020. The originating pre-solicitation was posted November 15, 2019, with a proposal due date of November 25, 2019.</p>
- This is a firm fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS), to Illumina, Inc. The contract, valued at $72,422.58, is for the provision of Illumina's sequencing instruments, reagents, and related products and services to support NIDDK's genomic research and analysis needs. Illumina has previously served as a prime contractor and...
- This is a firm fixed price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. The contract, valued at $80,449.94, is for the provision of Illumina's sequencing and analytical instruments and reagents to support NIDDK's genomic research and diagnostics efforts. The contract has no set-aside designation. Illumina has previously been awarded prime...
- This is a firm fixed price service contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the National Institutes of Health (NIH), to Illumina, Inc. for a Bronze Support Plan for a HiSeq 2500 sequencing instrument and a cBOT instrument. The total ceiling value of the contract is $34,456.50 and the period of performance is from June 23, 2019 through June 22, 2020. The contract was not set aside for any small business programs....
- The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $14,074 firm fixed price purchase order to Illumina, Inc. of San Diego, California. Under the contract, Illumina will provide unspecified products or services to NIH/NIDDK in support of the agency's biomedical research efforts. The contract has a period of performance of just over one year, running from April 20, 2018 through April 11, 2019. No...
- This is a $5,216.64 firm fixed price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc. for the provision of sequencing systems, reagents, and related services. The award has no set-aside designation. Illumina, a for-profit manufacturer, has previously supported genomic sequencing and analysis efforts across various federal agencies including the NIH, CDC, USDA,...